Amphastar Pharmaceuticals (AMPH) PT Lowered to $32 at Piper Sandler; 'A Tough 2025 Ahead'
Tweet Send to a Friend
Piper Sandler analyst David Amsellem lowered the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $32.00 (from $36.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
